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We all age. The questions that surround 
this one of life’s certainties are: why are we 
aging?” “What are the mechanisms of aging?” 
“Can we delay aging?” “Can we continue to 
be productive even late in life?” The search 
for the fountain of youth started thousands 
of years ago. However, only recently have 
advances in the genetics of aging started 
to reveal some answers to these questions. 
Aging is a complex process associated with 
the accumulation of age-related changes, 
and it is characterized by a progressive 
decline of physiological functions, increased 
frailty, and increased incidence of diseases. 
For years this was thought to be result of 
a passive decline due to wear and tear and 
accumulation of damage, a process that was 
not genetically regulated. Only in the last 
several decades have many groundbreaking 
discoveries clearly shown that aging is reg-
ulated. A genetic component of aging was 
first discovered in 1983 when Klass (1983) 
reported a longevity extension of C. elegans 
associated with gene mutations. Friedman 
and Johnson, (1988) mapped this longevity 
extension to the age-1 gene mutation and 
Kenyon’s et al. (1993) group identified the 
daf-2 longevity gene mutation. The identi-
fications of age-1 and daf-2mutations were 
truly groundbreaking discoveries. First, they 
showed that single gene mutations could 
affect aging. Second, they encouraged the 
search for and identification of other single 
gene mutations that affect longevity. Lastly, 
since AGE-1 (phosphatidylinositol-3-OH 
kinase catalytic subunit) and DAF-2 (insu-
lin receptor-like protein) are members of 
the insulin/IGF-1/FOXO signaling pathway, 
they revealed major role of the insulin sign-
aling in aging (Morris et al., 1996; Kimura 
et al., 1997). Although it was known that 
genes are highly conserved across the spe-
cies, it was extremely exciting to see that 
mutations in insulin/IgF-1/FOXO signal-
ing affect longevity in other species such as 
yeast, flies, and mice (Fabrizio et al., 2001; 
Clancy et al., 2001; Tatar et al., 2001; Taguchi 
et al., 2007; Kenyon, 2010). Remarkably, 
FOXO DNA variants have been   associated 
with exceptional longevity in several pop-
ulations (Kuningas et al., 2007; Willcox 
et al., 2008; Flachsbart et al., 2009). These 
discoveries also showed the advantage of 
using genetic model organisms such as 
yeast, worms, flies, and mice in longev-
ity studies and the likelihood of translat-
ing our findings from invertebrate model 
organisms to mammals. Since the role of 
the insulin/IgF-1 signaling was discovered, a 
number of pathways involved in determina-
tion of longevity have been identified such 
as the Sirtuin family (Sir2), the Target of 
rapamycin (Tor) signaling pathway, AMP 
kinase, JNK signaling. Since many of these 
pathways alter metabolism and catabolism, 
respiration, and protein synthesis have also 
been implicated in longevity extension 
(Kaeberlein et al., 1999; Kapahi et al., 2004; 
reviewed in Kenyon, 2010). One potential 
application of this knowledge is to develop 
drugs that affect some of these pathways. 
Rapamycin is one of the examples of such 
a drug, as it extends longevity in mice, and 
flies by affecting the Tor signaling pathway 
(Harrison et al., 2009; Bjedov et al., 2010). 
Recently studies in model organisms have 
been complimented by longitudinal stud-
ies in humans, which provide an unbiased 
approach to identify genetic variants that 
contribute to longevity. Particularly, stud-
ies in centenarians have already contributed 
to our knowledge of the aging process by 
revealing the association of specific geno-
types with longer life span (Barzilai and 
Gabriely, 2010).
Remarkably, longevity extensions associ-
ated with single gene mutations are often 
associated with a variety of beneficial effects 
on physiology and functions of long lived 
animals and could be seen as delayed accu-
mulation of age-related changes and pres-
ervation of functions late in life. This again, 
illustrates that a single gene mutation initi-
ates cascade of changes in gene expression 
and function, which all contribute to the 
well being of the whole organism. One of 
the grand challenges in genetics of aging is 
to determine how changes in single genes 
affect other genes and pathways. How do 
these networks interact and how does this 
interaction influence the aging process?
Another remarkable finding that 
changed our knowledge about aging is the 
discovery that aging can be affected by the 
environment, mainly by exposure to differ-
ent nutrients and stress. Calorie restriction 
(CR) is an environmental manipulation 
that delays age-related changes and extends 
longevity in a wide variety of species first 
described in McCay et al. (1935). Although 
several genetic components of the CR lon-
gevity pathway have been identified, such 
as the Sirtuin family of genes, the Tor and 
the insulin-signaling pathway, the grand 
challenge is to determine the exact mecha-
nism of the CR effect. Sir2 is thought to 
mediate some aspects of the CR response 
and has already been used as a target for 
drug screens to identify CR mimetic. These 
searches resulted in identification of sev-
eral compounds such as resveratrol, which 
extends longevity in yeast, worms, flies, and 
fish, but not in mice on regular diet and 
some studies (Howitz et al., 2003; Wood 
et al., 2004; reviewed in Agarwal and Baur, 
2011).
A major grand challenge in the genetics 
of aging is to harness the knowledge that 
could be gained by new genetics, molecular, 
and proteomics techniques. Genome-wide 
association (GWA) studies allow identifica-
tion of associations between single nucleo-
tide polymorphisms (SNPs) and longevity 
and may also reveal novel pathways that 
contribute to slowing aging (Barzilai and 
Gabriely, 2010). Advanced genetics tech-
niques, such as RNASeq, allow easy gen-
eration of large amounts of data, however, 
they also require sophisticated data analy-
sis in order to allow identification of addi-
tional layers of regulation such as alternative 
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  splicing, RNA-editing, miRNA, and other 
non-coding RNA, which could all affect 
aging process. For instance, several find-
ings illustrate the role of miRNA in aging 
and DR (De Lancastre et al., 2010; Khanna 
et al., 2011). Protein synthesis regulation 
and post-translational modifications may 
have significant roles in aging, and will be 
revealed by new proteomic techniques.
Lastly, the grand challenge in the genet-
ics of aging is to improve lives by using 
the knowledge of the role of specific genes 
and signaling pathways to find drugs that 
can slow aging and improve physiological 
function later in life. This would allow us 
to reach our ultimate goal – to find inter-
ventions that extend healthy life span. The 
goal of Frontiers in Genetics of Aging is to 
be a forum for publication of findings that 
will extend our understanding of the genetic 
and molecular basis of the aging process, 
and of the interaction between genes and 
the environment. Identification of new 
genes and new pathways involved in aging 
will open new possibilities for identification 
of the pharmacological treatments that pro-
mote health span, homeostasis, and longer 
life span.
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